Fagron N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FAGR.BR research report →
About the company
Fagron N. V. operates as a pharmaceutical compounding enterprise, dedicated to providing customized medicinal solutions for hospitals, pharmacies, clinics, and individual patients.
- CEO
- Rafael Padilla
- IPO
- 2007
- Employees
- 3,828
- HQ
- Nazareth, BE
Price Chart
- Market Cap
- $1.77B
- P/E
- 19.48
- P/S
- 1.86
- P/B
- 3.20
- EV/EBITDA
- 11.11
- Div Yield
- 1.66%
- Gross Margin
- 51.47%
- Op Margin
- 15.50%
- Net Margin
- 9.56%
- ROE
- 17.29%
- ROIC
- 11.09%
- Revenue
- $952.17M · 9.20%
- Net Income
- $91.02M · 12.99%
- EPS
- $1.25 · 13.64%
- Op Income
- $139.41M
- FCF YoY
- 35.10%
- 52W High
- $25.30
- 52W Low
- $19.24
- 50D MA
- $24.12
- 200D MA
- $22.03
- Beta
- 0.38
- Avg Volume
- 110.96K
Get TickerSpark's AI analysis on FAGR.BR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FAGR.BR coverage
Recent articles, reports, and earnings notes.
No research on FAGR.BR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FAGR.BR report →Similar companies
Peers in the same neighborhood.